{
    "code": "02022021",
    "time": "2015-06-25 16:23:13",
    "許可證字號": "衛署藥輸字第022021號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/12\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "92\/07\/31",
    "發證日期": "86\/12\/26",
    "許可證種類": "製　劑",
    "舊證字號": "02020033",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202202100",
    "中文品名": "好樂彼妥注射液",
    "英文品名": "HALOPERIDOL DECANOATE INJECTION",
    "適應症": "躁病、精神病狀態、噁心、嘔吐、攻擊性與破壞性之行為障礙、舞蹈病。",
    "劑型": "270注射劑",
    "包裝": "盒裝 安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "HALOPERIDOL DECANOATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1316201100  瑞帝股份有限公司",
    "申請商地址": "台北巿中山區民生東路２段１８０號５樓",
    "主製造廠": {
        "製造廠名稱": "F020031100  F.H. FAULDING CO., LTD. (TRADING AS DAVID BULL LABORATORIES)",
        "製造廠廠址": "1-23 LEXIA PLACE, MULGRAVE VICTORIA 3170 AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100310",
            "成分名稱": "HALOPERIDOL DECANOATE",
            "含量描述": "70.52",
            "含量": "70.5200000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020220210001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022021&Seq=001&Type=9"
        }
    ]
}